Skip to content

Luja Coude 20104Recalls & reported problems

Coloplast A/S · Class 2

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 05701780263252), received between Jan 19, 2026 and Jan 27, 2026 — classified as 2 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 2 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2

Patient problems

  • Urinary Tract Infection2
  • Drug Resistant Bacterial Infection1
  • Hemorrhage/Blood Loss/Bleeding1
  • Sepsis1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryJan 27, 2026Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE AVAILABLE INFORMATION, IT WAS REPORTED ON (B)(6) 2026 THAT THE PATIENT ACQUIRED AN INFECTION WHILE USING SPEEDICATH COUDE (20104 LOT 10294663 FROM BYRAM). THE PATIENT WAS HOSPITALIZED FOR UTI AND SEPSIS. WITHOUT THE BENEFIT OF EXAMINATION AND TESTING, COLOPLAST IS PRECLUDED FROM COMMENTING ON THE CONDITION OF THE DEVICE OR THE CAUSE OF THE OCCURRENCE. SHOULD ADDITIONAL FACTS PROMPT US TO ALTER OR SUPPLEMENT ANY INFORMATION OR CONCLUSIONS CONTAINED IN THE ORIGINAL MDR OR IN ANY PRIOR SUPPLEMENTAL REPORTS, A FOLLOW-UP REPORT WILL BE SUBMITTED.

    Patient problems: Sepsis; Urinary Tract Infection

    MAUDE report 24188739 ↗
  • InjuryJan 19, 2026Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE AVAILABLE INFORMATION, THIS COMPLAINT CONCERNS A PATIENT WHO HAS USED THE LUJA COUDE URINARY INTERMITTENT DRAINAGE CATHETER FOR ABOUT A MONTH. THE PATIENT¿S WIFE REPORTED THAT THE END USER HAS EXPERIENCED BLEEDING ONCE IN A WHILE AND DEVELOPED A UTI THAT RESULTED IN AN OVERNIGHT HOSPITAL STAY WITH IV ANTIBIOTICS. THE END USER WAS SENT HOME WITH ANTIBIOTICS AND IS NO LONGER SYMPTOMATIC. IT IS REPORTED THAT THE BLEEDING WAS VISIBLE IN THE CATHETER AND/OR THE URINE. THE PATIENT DID NOT FORCE THE CATHETER INTO THE URETHRA AND BLADDER. THE BLEEDING STOPPED IMMEDIATELY AFTER THE CATHETER WAS REMOVED. THERE WERE NO OTHER HEALTH EFFECTS BESIDES THE BLEEDING. THEY RECEIVED TRAINING ON HOW TO USE THE CATHETER AND DID SO ACCORDING TO THE IFU. NO FURTHER INFORMATION IS AVAILABLE AT THIS TIME. WITHOUT THE BENEFIT OF EXAMINATION AND TESTING, COLOPLAST IS PRECLUDED FROM COMMENTING ON THE CONDITION OF THE DEVICE OR THE CAUSE OF THE OCCURRENCE. SHOULD ADDITIONAL FACTS PROMPT US TO ALTER OR SUPPLEMENT ANY INFORMATION OR CONCLUSIONS CONTAINED IN THE ORIGINAL MDR OR IN ANY PRIOR SUPPLEMENTAL REPORTS, A FOLLOW-UP REPORT WILL BE SUBMITTED.

    Patient problems: Drug Resistant Bacterial Infection; Hemorrhage/Blood Loss/Bleeding; Urinary Tract Infection

    MAUDE report 24109085 ↗

Other Catheter, straight devices

All Catheter, straight devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.